Cardiothoracic Surgical Trials Network (CTSN) Linked Clinical Research Centers
NHLBI will soon fund research expanding an international cardiac surgery platform to include broader heart, lung, blood, and sleep studies, fostering collaboration and training to advance cardiovascular health innovations.
Funder: National Institutes of Health
Due Dates: June 1, 2026 (Estimated)
Funding Amounts: Not yet specified; details to be announced in the official NOFO.
Summary: Supports expansion of an international cardiac surgery research platform, advancing clinical trials and implementation science to improve cardiovascular health.
Key Information: This is a forecasted opportunity; applications are not yet being accepted.
Description
The National Heart, Lung, and Blood Institute (NHLBI) intends to release a Notice of Funding Opportunity (NOFO) for cooperative agreements supporting the expansion of an international cardiac surgery research platform. The initiative aims to broaden the platform’s scope beyond interventional cardiology and peri-operative care to include additional heart, lung, blood, and sleep (HLBS) research areas such as dissemination and implementation science, circadian medicine, and mechanistic science.
The enhanced platform will foster collaboration among academia, small businesses, professional societies, foundations, and international research entities to develop and accelerate innovative techniques, technologies, devices, pharmaceutical and bioengineered products, and strategies for improving the health of adults with cardiovascular disease and related neurologic complications. Additionally, the platform will serve as a centralized resource for training the next generation of clinical trialists and implementation researchers.
Applications are not being solicited at this time; this advance notice is intended to provide potential applicants with ample time to establish collaborations and develop responsive projects.
